FDA-Drug2024-02-07Class II
Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-659-06
Hazard
Subpotent Drug and Failed Impurities/Degradation Specifications
Sold states
Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.
Affected count
165,60 bottles
Manufactured in
Harborplace Tower, 111 S Calvert St Fl 21st, Baltimore, MD, United States
Products
Rifampin Capsules USP 300mg, 30-count bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-659-06
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0284-2024More Lupin Pharmaceuticals Inc. recalls
- FDA-Drug2026-07-08Lupin Pharmaceuticals prednisolone acetate eye drops recalled for foreign substance contamination
- FDA-Drug2026-07-08Lupin Glucagon Emergency Kit recalled for syringe plunger functionality defect
- FDA-Drug2026-05-27Lupin Liraglutide Injection recalled for particulate matter in cartridges
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief